GET A PIECE OF PHIZZLE
Phizzle’s software platform provides large-scale pharma companies means to digitize drug production data, which is integral to ensuring the safety and efficacy of cancer drugs and other FDA-regulated prescription medications.
Since 2005, Phizzle has been dedicated to creating innovative consumer and machine data solutions. To the best of our knowledge, ours is the only SaaS-based IoT software to remotely operate multiple scientific instrument brands and systems from a single, cloud-based user interface. Our novel approach has gained FDA-clearance and proof of concept validation through contract work with Fortune 75 pharma clients.
Phizzle is poised to partner with the world’s largest pharmaceutical companies by providing a solution that integrates with existing manufacturing systems and equipment. On a global scale, the installed base of scientific lab instruments exceeds 1M units across pharma, life sciences, clean manufacturing, food production, medical environments and office buildings. The market for these devices is growing, with particle counters, for example, projected at a 9% CAGR through 2027.*
*Information from Credible Markets, "Global Market Industry Value, Size, Share, Growth, Trends and Forecast, 2016-2027" for Analytical Balances, PH Meters, Particle Counters.
Phizzle’s cloud-native, microservices-based software platform offers world-leading pharmaceutical enterprises a solution to upgrade existing equipment, so they can produce life-saving medications with improved safety, compliance, and cost-efficiency.
Using our FDA-compliant system, drug companies are able to automate operations and enable optimized workflows, while also ensuring data integrity and minimizing the potential for human error. We believe ours is the first scalable platform of its kind targeting an entire ecosystem of devices waiting to be digitized across a landscape of laboratories worldwide.
The Problem & Our Solution
While the pharmaceutical industry is known for innovation, very little has changed in the world of drug production data. In order to be compliant with regulations and safety standards, laboratories rely on a variety of scientific instruments – including particle counters, balances, pH meters, and other equipment spanning decades of different makes and models – to manufacture pharmaceuticals.
For most companies, no central platform has previously existed to harmonize operations. As such, lab technicians still conduct a majority of testing manually, which results in a wide margin for human error. When mistakes happen, entire batches of product must be discarded and the recall process can total hundreds of millions of dollars, such as Pfizer’s infamous Bextra recall.
In order to avoid these kinds of costly errors, as well as ensure a safer and more streamlined production process, Phizzle has developed the digital architecture needed to capture this data holistically. Using our EDGMaker software platform, technicians are provided with all of the information from individual instruments on one digitized dashboard, which can be accessed and operated remotely.
*Testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.
(source)
*Testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.
(source)
Phizzle has contracted with universities across the country to bring pharmaceutical device technology to the broader public - specifically air quality testing after the initial outbreak of COVID-19.
Scientific lab instruments are some of the best tools in the world for diagnosis and measurement. Phizzle works with institutions like the University of Arizona to use them for quantifying and improving air quality on campuses.
For example, our particle counter testing at University of Arizona showed consistent and predictable "bad air" spikes during highly-trafficked hours at the largest student center. Data also indicated consistently bad air in the most trafficked reception area because the floor trash cans were placed next to the front desk where students waited. They were rarely emptied throughout the day and an easy change to make for the university.
Arizona changed the location of their trash and shifted foot traffic during COVID-19 to improve air quality and help keep students safe. Phizzle provided the device know-how and platform to implement immediate and actionable changes during this process.
The Market & Our Traction
For the past few years, Phizzle has been making significant strides to establish the EDGMaker software stack as an industry-innovating technology. Our platform is unique to the market, in that it has already secured FDA approval for our use case and designation for virtualizing scientific lab instruments. With this clearance in place, the company has gained a competitive edge and accomplished proof of concept by partnering with its first Fortune 75 pharmaceutical manufacturer.
Through our work we’ve been able to successfully digitize more than 40K samples from facilities producing one of the world’s best-selling cancer treatment drugs, and are on pace to reach 100K by the end of this year.
(source)
We’ve also effectively doubled our total addressable market by adding three new scientific lab instruments to our portfolio, and been recognized by Forbes.com, CRN, and the IoT Community.
Why Invest
Although Phizzle started as a small technology company, achieving FDA-compliant status and signing with a Fortune 75 pharma customer are a testament to the technology we've developed and our in-market advantage.
As we surpass our goal of 100K digitized samples and continue to grow our pipeline of potential customers to include other large-scale pharmaceutical customers, support from funding will allow us to expand our resources and serve the industry on a global scale. Help us continue on our trajectory to success by investing today!
Phizzle is a market leader in automating and digitizing scientific lab instruments used in pharma and other clean manufacturing environments. The vast majority of these instruments are not connected to a cloud based solution to harmonize or digitize their data. Phizzle is a first-mover in this market with a patented IoT solution that can remotely operate multiple types and vendors of lab instruments from the cloud. Phizzle has a recurring revenue contract with a Fortune 75 company and is FDA-compliant in its use case, which we believe is the first of its kind. The company is seeking funding to scale its operations and accelerate its current pipeline.
William Valtos
Director
Professional Expertise: A former investment banking CEO, Mr. Valtos has a deep network and extensive deal experience in Silicon Valley, Southeast Asia, and Japan. He has managed a number of businesses in different geographies and has cross-border experience in mergers and acquisition, capital markets strategy, venture capital, private equity, and strategic finance. Mr. Valtos co-founded and led a Top-Quartile venture capital firm, tracked. He is well-regarded for building strong corporate cultures and committed teams, organizational change, and corporate governance.
James Whims
Director
Kari Baker
VP Customer Success & Operations
Thomas Toy
Director
Stephen Peary
Chief Financial Officer and General Counsel
Ryan Brady
Chief Technical Officer
Ron Ricci
Chair of Board
Mark Krentzman
Director
Mr. Krentzman has a strong track record as an entrepreneur in working with software, medical technology, internet and telecommunications businesses, both in connection with fundraising and identifying significant opportunities for investment and growth in these fields, as well as helping in the turnaround of under-performing companies and creating significant value for shareholders.
Mr. Krentzman received a MBA from the Harvard University Graduate School of Business with an emphasis on manufacturing and marketing, and a BS in Finance, Magna Cum Laude, from Northeastern University School of Business. He currently serves as an Emeritus Corporator of Northeastern University and served as Co-Chair of his HBS Alumni Class. He also serves as a Trustee Emeritus of the Norman Rockwell Museum in Stockbridge, MA. Mr. Krentzman Is an Owner of Jones & Vining.
Edwin Lau
Director and Acting President
Michael Patrick
Chief Innovation Officer
Lena Wu
Industry Advisor
Cecilie Carter
Senior Director
Maximum Number of Shares Offered subject to adjustment for bonus shares
Voting Rights of Securities Sold in this Offering
Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), Chairman of the Board of Directors, or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives and Bonuses*
Time Based Bonus
Friends and Family Early Birds
Invest $200 within the first 48 hours and receive 20% bonus shares.
Super Early Bird Bonus
Invest $200 within the first week and receive 15% bonus shares.
Early Bird Bonus
Invest $200 within the first month and receive 10% bonus shares.
Amount-Based:
$500+ | Tier 1
Invest $500+ and receive 5% bonus shares.
$1,000+ | Tier 2
Invest $1,000+ and receive 10% bonus shares.
$5,000+ | Tier 3
Invest $5,000+ and receive 15% bonus shares.
$10,000+ | Tier 4
Invest $10,000+ and receive 20% bonus shares.
$20,000+ | Tier 5
Invest $20,000+ and receive 20% bonus shares and an invite to a webinar with the CEO
Loyalty Bonus:
As you are an existing Stockholder / Noteholder/ TTW Email recipient in Phizzle, receive 10% Additional Bonus Shares.
*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
Phizzle, Inc will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $0.40/ share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $40. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and the time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus and an audience-based bonus of 10% for Phizzle Existing Stockholders/Noteholders/TTW Email Recipients, in addition to the aforementioned bonus.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments. Salary payments made to one’s self, a friend or relative. Any expense labeled “Travel and Entertainment”.
Members get an extra 10% shares in addition to rewards below!
0/2500
9 months ago
1
0
9 months ago
1
0
9 months ago
1
0
10 months ago
1
0
10 months ago
1
0
10 months ago
1
0
10 months ago
1
0
10 months ago
1
0
10 months ago
1
0
Cancel anytime before 48 hours before a rolling close or the offering end date.
We want you to succeed and get the most out of your money by offering rewards and memberships!
Your info is your info. We take pride in keeping it that way!
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
Important Message
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.
www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRASIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.Investment opportunities posted and accessible through the site are of three types:
1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.
Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.
California Investors Only – Do Not Sell My Personal Information(800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.
StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.StartEngine Marketplace
The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine.
None of the information displayed on or downloadable from www.startengine.com (the 'Website') represents a recommendation, offer, or solicitation of an offer to buy or sell any security. It also does not constitute an offer to provide investment advice or service. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, or (2) assist in the determination of fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.
All investment opportunities are based on indicated interest from sellers and will need to be confirmed.
Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment.
StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC. StartEngine Bulletin Board ("SE BB") is a bulletin board platform that advertises interest in shares of private companies that previously executed Reg CF or Reg A offerings. SE BB enables shareholders to communicate interest in potential sales of shares in private companies and investors to discover, review, and potentially invest in private companies. As a bulletin board platform, SE BB provides a venue for investors to access information about private company offerings and connect with potential sellers. SE BB is distinct and separate from StartEngine Secondary (“SE Secondary”), which is an SEC-registered Alternative Trading System (ATS) operated by SE Primary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. While a security may be displayed on the bulletin board, these securities will be subject to certain restrictions which may prevent the ability to buy and sell these securities in a timely manner, if at all. Even if a security is qualified to be displayed on the bulletin board, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.
Archibald Mcgeoch
9 months ago
1
0